Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease

Journal of Lipid Research

Volumn 41, Issue 6, 2000, Pages 963-974

  Demeester, N ^a   Castro, G ^c   Desrumaux, C ^a   De Geitere, C ^c   Fruchart, J C ^c   Santens, P ^b   Mulleners, E ^d   Engelborghs, S ^d   De Deyn, P P ^d   Vandekerckhove, J ^a   Rosseneu, M ^a   Labeur, C ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c INSTITUT PASTEUR DE LILLE   (France)

^d NONE

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Cholesterol; Efflux; Lipoproteins

Indexed keywords

ACYLTRANSFERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; CHOLESTEROL DERIVATIVE; LIPID TRANSFER PROTEIN; LIPOPROTEIN; PHOSPHATIDYLCHOLINE;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CEREBROSPINAL FLUID; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENZYME ANALYSIS; HUMAN; LIPID ANALYSIS; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHOLESTEROL; HUMANS; LIPOPROTEINS; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RATS; ULTRACENTRIFUGATION;

EID: 17744421360     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Alberts, M. J., C. Graffagnino, C. McClenny, D. DeLong, W. Strittmatter, A. M. Saunders, and A. D. Roses. 1995. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 346: 575.
2. Helisalmi, S., K. Linnaranta, M. Lehtovirta, A. Mannermaa, O. Heinonen, M. Ryynanen, P. S. Riekkinen, and H. Soininen. 1996. Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci. Lett. 205: 61-64.
3. Nicoll, J. A., G. W. Roberts, and D. I. Graham. 1995. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat. Med. 1: 135-137.
4. Pitas, R. E., J. K. Boyles, S. H. Lee, D. Hui, and K. H. Weisgraber. 1987. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262: 14352-14360.
5. Utermann, G. 1994. Alzheimer's disease. The apolipoprotein E connection. Curr. Biol. 4: 362-365.
6. Pillot, T., M. Goethals, J. Najib, C. Labeur, L. Lins, J. Chambaz, R. Brasseur, J. Vandekerckhove, and M. Rosseneu. 1999. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease. J. Neurochem. 72: 230-237.
7. Hass, S., F. Fresser, S. Kochl, K. Beyreuther, G. Utermann, and G. Baier. 1998. Physical interaction of ApoE with amyloid precursor protein independent of the amyloid beta region in vitro. J. Biol. Chem. 273: 13892-13897.
8. LaDu, M. J., S. M. Gilligan, J. R. Lukens, V. G. Cabana, C. A. Reardon, L. J. Van Eldik, and D. M. Holtzman. 1998. Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70: 2070-2081.
9. Rebeck, G. W., N. C. Alonzo, O. Berezovska, S. D. Harr, R. B. Knowles, J. H. Growdon, B. T. Hyman, and A. J. Mendez. 1998. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APO E genotypes. Exp. Neurol. 149: 175-182.
10. Borghini, I., F. Barja, D. Pometta, and R. W. James. 1995. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim. Biophys. Acta. 1255: 192-200.
11. Roheim, P. S., M. Carey, T. Forte, and G. L. Vega. 1979. Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA. 76: 4646-4649.
12. Guyton, J. R., S. E. Miller, M. E. Martin, W. A. Khan, A. D. Roses, and W. J. Strittmatter. 1998. Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ ml in human cerebrospinal fluid. J. Neurochem. 70: 1235-1240.
13. Simons, M., P. Keller, B. De Strooper, K. Beyreuther, C. G. Dotti, and K. Simons. 1998. Cholesterol depletion inhibits the generation of beta-amyoid in hippocampal neurons. Proc. Natl. Acad. Sci. USA. 95: 6460-6464.
14. Racchi, M., R. Baetta, N. Salvietti, P. Ianna, G. Franceschini, R. Paoletti, R. Fumagalli, S. Govoni, M. Trabucchi, and M. Soma. 1997. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem. J. 322: 893-898.
15. Bodovitz, S., and W. L. Klein. 1996. Cholesterol modulates alpha-secretase cleavage of amyoid precursor protein. J. Biol. Chem. 271: 4436-4440.
16. Mulder, M., R. Ravid, D. F. Swaab, E. R. de Kloet, E. D. Haasdijk, J. Julk, J. J. van der Boom, and L. M. Havekes. 1998. Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis. Assoc. Disord. 12: 198-203.
17. Svennerholm, L., K. Bostrom, B. Jungbjer, and L. Olsson. 1994. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J. Neurochem. 63: 1802-1811.
18. Castro, G. R., and C. J. Fielding. 1988. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry. 27: 25-29.
19. Ito, J., L. Y. Zhang, M. Asai, and S. Yokoyama. 1999. Differential generation of high density lipoprotein by endogenous apolipoproteins in cultured fetal rat astrocytes. J. Neurochem. 72: 2362-2369.
20. McKahnn, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer's Disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 34: 939-944.
21. Rosseneu, M., and J. Bury. 1988. Apolipoprotein assays for the diagnosis of hyperlipidemias. Prog. Clin. Biol. Res. 255: 143-154.
22. Labeur, C., J. Shepherd, and M. Rosseneu. 1990. Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin. Chem. 36: 591-597.
23. Desrumaux, C., A. Athias, G. Bessede, B. Verges, M. Farnier, L. Persegol, P. Gambert, and L. Lagrost. 1999. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. Arterioscler. Thromb. Vasc. Biol. 19: 266-275.
24. Peelman, F., N. Vinaimont, A. Verhee, B. Vanloo, J. L. Verschelde, C. Labeur, S. Seguret-Mace, N. Duverger, G. Hutchinson, J. Vandekerckhove, J. Tavernier, and M. Rosseneu. 1998. A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling. Protein Sci. 7: 587-599.
25. Menzel, H. J., and G. Uterman. 1986. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis. 7: 492-495.
26. Matz, C. E., and A. Jonas. 1982. Micellar complexes of human apolipoproiein A-I with phosphatidylcholine and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257: 4535-4540.
27. Vanloo, B., F. Peelman, K. Deschuymere, J. Taveirne, A. Verhee, C. Gouyette, C. Labeur, J. Vandekerckhove, J. Tavernier, and M. Rosseneu. 2000. J. Lipid Res. 41: 752-761.
28. Guyard-Dangremont, V., L. Lagrost, P. Gambert, and C. Lallemant. 1994. Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein. Clin. Chim. Acta. 231: 147-160.
29. Huuskonen, J., V. M. Olkkonen, M. Jauhiainen, J. Metseo, P. Somerharju, and C. Ehnholm. 1996. Acyl chain and headgroup specificity of human plasma phospholipid transfer protein. Biochim. Biophys. Acta. 1303: 207-214.
30. Vercaemst, R., A. Union, M. Rosseneu, I. De Craene, G. De Backer, and M. Kornitzer. 1989. Quantitation of plasma free cholesterol and cholesteryl esters by high performance liquid chromatography. Study of a normal population. Atherosclerosis. 78: 245-250.
31. Leveugle, B., W. Ding, F. Laurence, M. P. Dehouck, A. Scanameo, R. Cecchelli, and H. Fillit. 1998. Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide. J. Neurochem. 70: 736-744.
32. Knebl, J., P. DeFazio, M. B. Clearfield, L. Little, W. J. McConathy, R. McPherson, and A. G. Lacko. 1994. Plasma lipids and cholesterol esterification in Alzheimer's disease. Mech. Ageing Dev. 73: 69-77.
33. Albers, J. J., S. M. Marcovina, and R. H. Christenson. 1992. Lecithin:choleslerol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain. Int. J. Clin. Lab. Res. 22: 169-172.
34. Strittmatter, W. J., and A. D. Roses. 1995. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92: 4725-4727.
35. van Duijn, C. M., P. de Knijff, M. Cruts, A. Wehnert, L. M. Havekes, A. Hofman, and C. Van Broeckhoven. 1994. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat. Genet. 7: 74-78.
36. Polvikoski, T., R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinisto, P. Halonen, and K. Kontula. 1995. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N. Engl. J. Med. 333: 1242-1247.
37. Csaszar, A., J. Kalman, C. Szalai, Z. Janka, and L. Romics. 1997. Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease. Neurosci. Lett. 230: 151-154.
38. Montine, K. S., C. N. Bassett, J. J. Ou, W. R. Markesbery, L. L. Swift, and I. J. Montine. 1998. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproleins. J. Lipid Res. 39: 2443-2451.
39. Albers, J. J., J. H. Tollefson, G. Wolfbauer, and R. E. J. Albright. 1992. Cholesterol ester transfer protein in human brain. Int. J. Clin. Lab. Res. 21: 264-266.
40. Blennow, K., C. Hesse, and P. Fredman. 1994. Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport. 5: 2534-2536.
41. Landen, M., G. Hesse, P. Fredman, B. Regland, A. Wallin, and K. Blennow. 1996. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apo E4 isoform. Dementia. 7: 273-278.
42. Skoog, I., C. Hesse, P. Fredman, L. A. Andreasson, B. Palmertz, and K. Blennow. 1997. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. Arch. Neurol. 54: 267-272.
43. Pirttila, T., K. Koivisto, P. D. Mehta, K. Reinikainen, K. S. Kim, O. Kilkku, E. Heinonen, H. Soininen, P. S. Riekkinen, and H. M. Wisniewski. 1998. Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprolein E in patients with probable Alzheimer's disease. Neurosci. Lett. 249: 21-24.
44. Yamauchi, K., M. Tozuka, T. Nakabayashi, M. Sugano, H. Hidaka, Y. Kondo, and T. Katsuyama. 1999. Apolipoprotein E in cere-brospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations. Clin. Chem. 45: 497-504.
45. Yamauchi, K., M. Tozuka, H. Hikada, K. Hidaka, Y. Kondo, and T. Katsuyama. 1999. Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E. Clin. Chem. 45: 1431-1438.
46. de Vries, H. E., B. Breedveld, J. Kuiper, A. G. de Boer, T. J. Van Berkel, and D. D. Breimer. 1995. High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transport. Biochem. Pharmacol. 50: 271-273.
47. Poirier, J., M. Hess, P. C. May, and C. E. Finch. 1991. Cloning of hippocampal poly(A) RNA sequences that increase alter entorhinal cortex lesion in adult rat. Brain Res. Mol. Brain Res. 9: 191-195.
48. Harr, S. D., L. Uint, R. Hollister, B. T. Hyman, and A. J. Mendez. 1996. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J. Neurochem. 66: 2429-2435.
49. Koudinov, A. R., N. V. Koudinova, and T. T. Berezov. 1996. Alzheimer's peptides A beta 1-40 and A beta 1-28 inhibit the plasma cholesterol esterification rate. Biochem. Mol. Biol. Int. 38: 747-752.
50. de Knijff, P., M. Rosseneu, U. Beisiegel, W. de Keersgieter, R. R. Frants, and L. M. Havekes. 1988. Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J. Lipid Res. 29: 1621-1627.
51. Koudinov, A. R., N. V. Koudinova, A. Kumar, R. C. Beavis, and J. Ghiso. 1996. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins. Biochem. Biophys. Res. Commun. 223: 592-597.
52. Merched, A., Y. Xia, A. Papadopoulou, G. Siest, and S. Visvikis. 1998. Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease. Neurosci. Lett. 242: 117-119.
53. Fukagawa, K., D. S. Knight, K. A. Hamilton, and P. Tso. 1995. Immunoreactivity for apolipoprotein A-IV in tanycytes and astrocytes of rat brain. Neurosci. Lett. 199: 17-20.
54. von Eckardstein, A., Y. Huang, and G. Assmann. 1994. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr. Opin. Lipidol. 5: 404-416.
55. Okumura, T., K. Fukagawa, P. Tso, I. L. Taylor, and T. N. Pappas. 1996. Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am. J. Physiol. 270: G49-G53.
56. 2 techniques in vivo and in vitro. J. Biol. Chem. 272: 30178-30184.
57. Warden, C. H., C. A. Langner, J. I. Gordon, B. A. Taylor, J. W. McLean, and A. J. Lusis. 1989. Tissue-specific expression, developmental regulation, and chromosomal mapping of the leciihin:cholesterol acyltransferase gene. Evidence for expression in brain and testes as well as liver. J. Biol. Chem. 264: 21573-21581.
58. Collet, X., O. Francone, F. Besnard, and C. J. Fielding. 1999. Secretion of lecithin:cholesterol acyltransferase by brain neuroglial cell lines. Biochem. Biophys. Res. Commun. 258: 73-76.
59. Quinet, E. M., P. Huerta, D. Naucoo, A. R. Tall, Y. L. Marcel, and R. McPherson. 1993. Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence. J. Lip Res. 34:845-852.
60. Albers, J. J., G. Wolfbauer, M. C. Cheung, J. R. Day, A. F. Ching, S. Lok, and A. Y. Tu. 1995. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim. Biophys. Acta. 1258: 27-34.
61. Drayna, D., A. S. Jarnagin, J. McLean, W. Henzel, W. Kohr, C. Fielding, and R. Lawn. 1987. Cloning and sequencing of the human cholesteryl ester transfer protein. Nature. 327: 632-634.